| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.093 | 0.003 |
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | 0.096 | 0.003 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | 0.098 | 0.003 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | -0.16 | 0.003 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.004 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.005 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.005 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | 0.087 | 0.006 |